A NEW STANDARD IN ADVANCED
WOUND DRESSINGS
LEVERAGING THE POWER OF COPPER
A NEW STANDARD IN ADVANCED
WOUND DRESSINGS
LEVERAGING THE POWER OF COPPER
MedCu is proud to be the first company
to gain FDA and CE clearances for marketing
copper-based wound dressings.
MedCu is proud to be the first company to gain FDA and CE clearances for marketing copper-based wound dressings.
MedCu Technologies is the world’s first provider of wound dressing products that are impregnated with copper oxide microparticles.
Leveraging copper’s potent antimicrobial properties, MedCu provides a unique proposition to address acute, critical and chronic wounds. The copper-based wound dressings follow the successful commercialization of copper compounds impregnation into various fabrics and polymers after 15 years of research and protected by multiple patents worldwide.
The Power Of Copper
Copper is an essential nutrient mineral with broad spectrum potent anti-microbial efficacy.
Proprietary Technology
Copper microparticles are embedded into fibers, substrates and polymers very early during production with no significant changes to the manufacturing process.
Medical Benefits
Used for wound management, health, and wellness purposes for thousands of years, Copper is safe, biocompatible, non-sensitizing and non-irritating to the skin.
RANGE OF PRODUCTS
MedCu dressings are single-use wound dressing with an internal absorbent layer and one or two external non-woven, non-adherent layers. All layers are impregnated with copper oxide particles. The dressings are non-irritant, non-sensitizing, and are available in 7 configurations, with or without an adhesive contour.
AREAS OF USE
MedCu dressings are easy to apply and remove and are suitable for a wide variety of wounds:
- • Diabetic Wounds
- • Leg & Foot Ulcers
- • Pressure Ulcers
- • First & Second-Degree Burns
- • Surgical Wounds
- • Arterial Ulcers
- • Venous Stasis Ulcers
BENEFITS
• Strong protection against a broad
spectrum of wound pathogens
• Cost effective, compared to
alternatives on the market
• Efficient non-adherent and pain free
removal
• Single dressing can be used for up
to 7 days
• Dressings can be trimmed to fit
the wound optimally
• Strong protection against a broad spectrum of wound pathogens
• Cost effective, compared to alternatives on the market
• Efficient adhering and pain free removal
• Single dressing can be used for up to 7 days
• Dressings can be trimmed to fit the wound optimally
Two Layers
Antimicrobial Dressing with
Copper Oxide
Centimeters
Inches
5 x 6 cm
2” x 2.4”
10 x 12 cm
4” x 4.5”
10 x 20 cm
4” x 8”
20 x 20 cm
8” x 8”
Two Layers with Adhesive
Antimicrobial Dressing with Copper Oxide and an Adhesive Contour
Centimeters
Inches
10 x 10 cm
(Internal 5 x 5)
4” x 4”
(Internal 2 x 2.2)
10 x 25 cm
(Internal 5 x 20)
4” x 10”
(Internal 2 x 7.8)
Three Layers
Antimicrobial Dressing with
Copper Oxide – appropriate for tunnels and deep wounds
Centimeters
Inches
10 x 12 cm
4” x 4.5”
Two Layers
Antibacterial Dressing with Copper Oxide
Centimeters
Inches
5 x 6 cm
2” x 2.4”
10 x 10 cm
4” x 4”
10 x 11.5 cm
4” x 4.5”
10 x 20 cm
4” x 8”
20 x 20 cm
8” x 8”
Two Layers with Adhesive
Antibacterial Dressing with Copper Oxide and an Adhesive Contour
Centimeters
Inches
10 x 10 cm
(Internal 5 x 5.5)
4” x 4”
(Internal 2 x 2.2)
10 x 25 cm
(Internal 5 x 20)
3.9” x 3.9”
(Internal 2 x 7.8)
Three Layers
Antibacterial Dressing with Copper Oxide
Centimeters
Inches
10 x 11.5 cm
4” x 4.5”
Resources
Articles
- Using copper to fight microorganisms
- Safety of copper oxide
- Could chronic wounds not heal due to too low local copper levels?
- Molecular mechanisms of enhanced wound healing by copper oxide-impregnated dressings
- Copper ions ameliorated thermal burn-induced damage
- Stimulation of Healing of Non-Infected Stagnated Diabetic Wounds
- Healing of Chronic Wounds 10 Case Studies
- Copper oxide impregnated wound dressing
Posters
Case studies
- The use of the copper dressing in difficult-to-heal wounds
- Fracture with acute wound (trauma cases): copper dressing is used inside the cast
- Significant improvement of large burn wound after 10 days
- Copper dressings prevent amputation in SLE patient
- Dramatic improvement of a venous ulcer infected with multidrug-resistant bacteria
- Necrotizing fasciitis arm ready for skin grafting in two weeks
- Closure of a 6-year indolent chronic wound in IDDM patient
- Exposed bone covered by granulation tissue in ischemic diabetic patient
- 35% wound area reduction/week following angioplasty of the left leg
- Increased epithelization in heel
- Clearance of infection, induction of granulation and epithelization
Certificates
News & Events
symposium on advanced wound care
Las Vegas, Nevada, USA
November 2 -5, 2023
European Wound Management Association
Düsseldorf, Germany
November 13-16, 2023
NEWS
21- 23.9.2023
MedCu attends VI FORUM LECZENIA RAN (Wound Care Forum) in Poland
1-7.2023
MedCu receives the Drug Tariff approval in the U.K.
3- 5.5.2023
MedCu attends EWMA in Milan
4- 5.3.2023
MedCu attends Abu Dhabi Wound Care Conference in UAE
13- 14.12.2022
MedCu attends Advanced Wound Care Summit in Berlin
14- 17.11.2022
MedCu attends MEDICA 2022 in Dusseldorf
13- 16.10.2022
MedCu attends SAWC Fall conference in Las Vegas
23- 25.5.2022
MedCu attends EWMA conference in Paris
6-10.4.2022
MedCu attends SAWC conference
1.03.2022
MedCu attends WUWHS conference
1.12.2021
MedCu moves to new corporate offices
15.11.2021
MedCu attends Medica Conference
9.5.20
Team
Danny Lustiger, CPA
Co-Founder & CEO
Over 20 years of high-tech and biomed experience, financials and general management. Previously was President and CEO of Cupron, a developer of copper embedded products into healthcare, consumer, industrial, and military applications. Before working at Cupron, Danny was CFO of Shikun & Binui, a global infrastructure corporation and GM and president of Optibase Inc.
Gadi Borkow, PhD
Co-Founder & CMO
Dr. Borkow is a Biochemist, Microbiologist and a world expert in Copper and its medical applications. As the Chief Medical Scientist of Cupron, Dr. Borkow has published over 130 manuscripts in scientific journals, serves as a reviewer of more than 50 scientific journals and NIH forums, and is on the Editorial Board of seven scientific journals.
Amir Carmeli
Chief Commercial Officer
Responsibility over MedCu’s sales, marketing and business development. Vast experience promoting technologies in different markets worldwide. Previously served as regional vice president at Gilat (NASDAQ: GILT) and executive vice president sales at Amos-Spacecom (TLV: SCC).
